Literature DB >> 30347482

Genetic and epigenetic contribution to astrocytic gliomas pathogenesis.

Pouria Khani1,2, Farzad Nasri3, Fateme Khani Chamani4, Farzane Saeidi5, Javid Sadri Nahand6, Alireza Tabibkhooei7, Hamed Mirzaei8.   

Abstract

Astrocytic gliomas are the most common and lethal form of intracranial tumors. These tumors are characterized by a significant heterogeneity in terms of cytopathological, transcriptional, and (epi)genomic features. This heterogeneity has made these cancers one of the most challenging types of cancers to study and treat. To uncover these complexities and to have better understanding of the disease initiation and progression, identification, and characterization of underlying cellular and molecular pathways related to (epi)genetics of astrocytic gliomas is crucial. Here, we discuss and summarize molecular and (epi)genetic mechanisms that provide clues as to the pathogenesis of astrocytic gliomas.
© 2018 International Society for Neurochemistry.

Entities:  

Keywords:  astrocytic glioma; molecular mechanism; therapy

Mesh:

Year:  2018        PMID: 30347482     DOI: 10.1111/jnc.14616

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  21 in total

Review 1.  The Story of Nanoparticles in Differentiation of Stem Cells into Neural Cells.

Authors:  Vajihe Asgari; Amir Landarani-Isfahani; Hossein Salehi; Noushin Amirpour; Batool Hashemibeni; Saghar Rezaei; Hamid Bahramian
Journal:  Neurochem Res       Date:  2019-11-12       Impact factor: 3.996

Review 2.  MicroRNAs and Synaptic Plasticity: From Their Molecular Roles to Response to Therapy.

Authors:  Amir Hossein Mohammadi; Seyedvahid Seyedmoalemi; Mahsa Moghanlou; Seyed Amirreza Akhlagh; Sayyed Alireza Talaei Zavareh; Michael R Hamblin; Ameneh Jafari; Hamed Mirzaei
Journal:  Mol Neurobiol       Date:  2022-06-06       Impact factor: 5.682

3.  MicroRNAs and exosomes: key players in HIV pathogenesis.

Authors:  J Sadri Nahand; F Bokharaei-Salim; M Karimzadeh; M Moghoofei; S Karampoor; H R Mirzaei; A Tabibzadeh; A Jafari; A Ghaderi; Z Asemi; H Mirzaei; M R Hamblin
Journal:  HIV Med       Date:  2019-11-22       Impact factor: 3.180

Review 4.  Cardiac complications in inherited mitochondrial diseases.

Authors:  Mohaddeseh Behjati; Mohammad Reza Sabri; Masood Etemadi Far; Majid Nejati
Journal:  Heart Fail Rev       Date:  2021-03       Impact factor: 4.214

5.  Molecular Biomarkers of Brain and Spinal Cord Astrocytomas.

Authors:  N A Konovalov; D S Asyutin; E G Shayhaev; S V Kaprovoy; S Yu Timonin
Journal:  Acta Naturae       Date:  2019 Apr-Jun       Impact factor: 1.845

6.  Multivariate analysis reveals differentially expressed genes among distinct subtypes of diffuse astrocytic gliomas: diagnostic implications.

Authors:  Nerea González-García; Ana Belén Nieto-Librero; Ana Luisa Vital; Herminio José Tao; María González-Tablas; Álvaro Otero; Purificación Galindo-Villardón; Alberto Orfao; María Dolores Tabernero
Journal:  Sci Rep       Date:  2020-07-09       Impact factor: 4.379

Review 7.  The Emerging Role of Circ-SHPRH in Cancer.

Authors:  Xinyue Ju; Yan Tang; Rongfeng Qu; Shuhong Hao
Journal:  Onco Targets Ther       Date:  2021-07-13       Impact factor: 4.147

8.  Expression profiling of human milk derived exosomal microRNAs and their targets in HIV-1 infected mothers.

Authors:  Muhammad Atif Zahoor; Xiao-Dan Yao; Bethany M Henrick; Chris P Verschoor; Alash'le Abimiku; Sophia Osawe; Kenneth L Rosenthal
Journal:  Sci Rep       Date:  2020-07-31       Impact factor: 4.379

9.  Differential expression of miR-1297, miR-3191-5p, miR-4435, and miR-4465 in malignant and benign breast tumors.

Authors:  Abbas Mosapour; Fatemeh Soghra Karami Tehrani; Morteza Atri
Journal:  Iran J Basic Med Sci       Date:  2020-08       Impact factor: 2.699

10.  From astrocytoma to glioblastoma: a clonal evolution study.

Authors:  Fuhua Yang; Yunding Zou; Qiang Gong; Jieping Chen; Wei-Dong Li; Qilin Huang
Journal:  FEBS Open Bio       Date:  2020-03-22       Impact factor: 2.693

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.